Select Region: North America | Germany | Japan  
 
 
Healthcare Professionals
HOME HAE AND YOU CLINICAL TRIALS ASK AN EXPERT FAMILY TREE JOURNAL
UNDERSTANDING HAE LIVING BETTER WITH HAE TREATING HAE FINDING MORE RESOURCES CONNECTING WITH HAE COMMUNITY

 
Email:
Password:
Forgot Password?



This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health
information:
verify here.

ASK AN EXPERT

Q: How is HAE treated?

A: HAE treatment can be divided into 2 categories: prophylaxis and treating acute attacks. Injecting purified C1-INH during HAE attacks has been used in many countries for almost 30 years. However, C1-INH has not yet been proven by the US Food and Drug Administration (FDA), so it is currently an investigational drug in the United States. In other countries, C1-INH has been used both for treating acute attacks and for preventing attacks.

An alternative treatment is fresh frozen plasma (FFP). In FFP, many blood protein products are preserved. FFP has been used to replace C1-INH in HAE patients during acute attacks and prophylaxis¿especially when C1-INH is not available.

Androgen derivatives, such as danazol and oxandrin, are often used as a prophylactic medicine for HAE.

Answered By: Dr. Henry Li, MD


Document Published: 12/22/2006 11:29 AM
Last Updated: 12/22/2006 11:30 AM

 

The information on allabouthae.com is offered solely as a service to Internet customers and is general in nature. It is not intended, nor should it be construed as medical advice. For specific medical advice regarding illnesses or injuries, please consult your personal healthcare provider or a physician or healthcare provider who is trained in that area of expertise. He or she can best advise you concerning your personal situation.

CSL Behring Biotherapies for Life
All About HAE

© 2010 CSL Behring | Home | Patients Site Map
Healthcare Professionals Site Map | Privacy | Terms of Use
About AllAboutHAE.com | HAEA.org | Contact Us